[go: up one dir, main page]

EP1430112A4 - NEW NUCLEIC ACIDS AND POLYPEPTIDES - Google Patents

NEW NUCLEIC ACIDS AND POLYPEPTIDES

Info

Publication number
EP1430112A4
EP1430112A4 EP02780359A EP02780359A EP1430112A4 EP 1430112 A4 EP1430112 A4 EP 1430112A4 EP 02780359 A EP02780359 A EP 02780359A EP 02780359 A EP02780359 A EP 02780359A EP 1430112 A4 EP1430112 A4 EP 1430112A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
nucleic acids
new nucleic
new
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02780359A
Other languages
German (de)
French (fr)
Other versions
EP1430112A2 (en
Inventor
Tom Y Tang
Jie Zhang
Feiyan Ren
Aidong J Xue
Qing A Zhao
Jian-Rui Wang
Tom Wehrman
Ping Zhou
Malabika Ghosh
Dunrui Wang
Yunqing Ma
Vinod Asundi
Zhiwei Wang
Gezhi Weng
Dana Haley-Vicente
Rodoje T Drmanac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Publication of EP1430112A2 publication Critical patent/EP1430112A2/en
Publication of EP1430112A4 publication Critical patent/EP1430112A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP02780359A 2001-09-24 2002-09-24 NEW NUCLEIC ACIDS AND POLYPEPTIDES Withdrawn EP1430112A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32463101P 2001-09-24 2001-09-24
US324631P 2001-09-24
PCT/US2002/030474 WO2003029271A2 (en) 2001-09-24 2002-09-24 Novel nucleic acids and polypeptides

Publications (2)

Publication Number Publication Date
EP1430112A2 EP1430112A2 (en) 2004-06-23
EP1430112A4 true EP1430112A4 (en) 2005-06-15

Family

ID=23264420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02780359A Withdrawn EP1430112A4 (en) 2001-09-24 2002-09-24 NEW NUCLEIC ACIDS AND POLYPEPTIDES

Country Status (4)

Country Link
EP (1) EP1430112A4 (en)
AU (1) AU2002343417A1 (en)
CA (1) CA2461280A1 (en)
WO (1) WO2003029271A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001286699A1 (en) 2000-08-22 2002-03-04 Agensys, Inc. Nucleic acid and corresponding protein named 158p1h4 useful in the treatment and detection of bladder and other cancers
US7358353B2 (en) 2000-08-22 2008-04-15 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
AU2002230831A1 (en) 2000-10-20 2002-04-29 Millennium Pharmaceuticals, Inc. Compositions of human proteins and method of use thereof
CA2443617C (en) * 2001-04-17 2013-12-10 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
US7309760B2 (en) * 2001-04-17 2007-12-18 The Board Of Trustees Of The University Of Arkansas Repeat sequences of the CA125 gene and their use for diagnostic and therapeutic interventions
FR2836687A1 (en) * 2002-03-04 2003-09-05 Gene Signal GENES INVOLVED IN THE REGULATION OF ANGIOGENESIS, PHARMACEUTICAL PREPARATIONS CONTAINING SAME AND THEIR APPLICATIONS
EP1639137A4 (en) * 2003-05-29 2008-04-23 Millennium Pharm Inc Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
GB0326197D0 (en) * 2003-11-10 2003-12-17 Randox Lab Ltd Molecular marker
JPWO2005111213A1 (en) * 2004-05-18 2008-03-27 学校法人 久留米大学 Myc target gene mimitin
EP1811023A4 (en) 2004-09-29 2009-04-29 Dainippon Sumitomo Pharma Co Gene expressed specifically in es cells and utilization of the same
GB0526212D0 (en) * 2005-12-22 2006-02-01 Imp College Innovations Ltd Methods
WO2008054534A2 (en) 2006-05-11 2008-05-08 Quark Pharmaceuticals, Inc. Screening systems utilizing rtp801
WO2007141796A2 (en) 2006-06-09 2007-12-13 Quark Pharmaceuticals, Inc. Therapeutic uses of inhibitors of rtp801l
EP2371377A1 (en) * 2007-02-09 2011-10-05 Gene Signal International SA Wound healing agent and composition
EP1980254A1 (en) * 2007-04-13 2008-10-15 Rijksuniversiteit te Groningen Means and methods for counteracting protein aggregation
US20100204128A1 (en) * 2007-07-24 2010-08-12 Sanare Investment As Novel peptides
US8614311B2 (en) 2007-12-12 2013-12-24 Quark Pharmaceuticals, Inc. RTP801L siRNA compounds and methods of use thereof
JP2013099253A (en) * 2010-03-11 2013-05-23 Intec Systems Institute Inc Diagnostic marker for lung cancer or cervical cancer
US8288334B2 (en) * 2010-06-14 2012-10-16 Gene Signal International Sa Peptides for wound healing
US20130210739A1 (en) * 2010-07-21 2013-08-15 Universite Pierre Et Marie Curie (Paris 6) Bhlh proteins and their use as drugs
US8871737B2 (en) 2010-09-22 2014-10-28 Alios Biopharma, Inc. Substituted nucleotide analogs
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
EP2828277A1 (en) 2012-03-21 2015-01-28 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
WO2013142157A1 (en) 2012-03-22 2013-09-26 Alios Biopharma, Inc. Pharmaceutical combinations comprising a thionucleotide analog
EA032908B1 (en) 2012-08-23 2019-08-30 Эдженсис, Инк. Antibody drug conjugates (adc) that bind to 158p1d7 proteins
MY193703A (en) 2015-03-27 2022-10-26 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
US20240218019A1 (en) * 2021-04-06 2024-07-04 Board Of Regents, The University Of Texas System Methods and compositions comprising mhc class i peptides

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (en) * 2000-04-18 2001-10-25 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002081629A2 (en) * 2001-04-03 2002-10-17 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750345A (en) * 1995-10-31 1998-05-12 Evanston Hospital Corporation Detection of human α-thalassemia mutations and their use as predictors of blood-related disorders
WO2001079449A2 (en) * 2000-04-18 2001-10-25 Hyseq, Inc. Novel nucleic acids and polypeptides
WO2002081629A2 (en) * 2001-04-03 2002-10-17 Curagen Corporation Novel human proteins, polynucleotides encoding them and methods of using the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [online] 18 December 2001 (2001-12-18), "Novel human secreted protein #547.", XP002314713, retrieved from EBI accession no. GSP:AAU30056 Database accession no. AAU30056 *
DATABASE Geneseq [online] 5 February 2003 (2003-02-05), "Human protein NOV20a.", XP002314714, retrieved from EBI accession no. GSP:ABU11055 Database accession no. ABU11055 *
DATABASE UniProt [online] 1 June 2001 (2001-06-01), "Hemoglobin alpha 1 globin chain (Fragment).", XP002314712, retrieved from EBI accession no. UNIPROT:Q9BX83 Database accession no. Q9BX83 *
DATABASE USPTO Proteins [online] 10 December 1998 (1998-12-10), "Sequence 3 from patent US 5750345.", retrieved from EBI accession no. USPOP:AR007678 Database accession no. AR007678 *

Also Published As

Publication number Publication date
AU2002343417A1 (en) 2003-04-14
CA2461280A1 (en) 2003-04-10
WO2003029271A3 (en) 2003-11-20
EP1430112A2 (en) 2004-06-23
WO2003029271A2 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
EP1381621A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1470238A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1430112A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1453967A4 (en) BGL5 BETA-GLUCOSIDASE AND NUCLEIC ACIDS ENCODING THE SAME
ATE554171T1 (en) RECEPTOR NUCLEIC ACIDS AND POLYPEPTIDES
EP1453968A4 (en) BGL4-BETA-GLUCOSIDASE AND THESE CODING NUCLEIC ACIDS
EP1427746A4 (en) PROTEIN AND NUCLEIC ACID EXPRESSION SYSTEMS
EP1472359A4 (en) EGVII ENDOGLUCANASE AND THESE CODING NUCLEIC ACIDS
EP1556490A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
DE02784674T1 (en) QUANTIFICATION OF POLYPEPTIDES
DK1689775T3 (en) GAG-binding proteins
DE60210864D1 (en) Modified fluorescent protein
EP1368475A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1357186A4 (en) NEW PROTEINS AND CORRESPONDING DNA
DK1330525T3 (en) NOD2 nucleic acids and proteins
EP1383533A4 (en) Proteins and nucleic acids encoding same
EP1695078A4 (en) METADHERINE POLYPEPTIDES ENCODING NUCLEIC ACIDS AND METHODS OF USE
EP1274716A4 (en) NEW NUCLEIC ACIDS AND NEW POLYPEPTIDES
EP1499723A4 (en) NEW NUCLEIC ACIDS AND POLYPEPTIDES
EP1498486A4 (en) NUCLEIC ACID LIBRARY AND PROTEIN LIBRARY
AU2002367841A8 (en) Bsnd nucleic acids and proteins
EP1398376A4 (en) NUCLEIC ACIDS ISOLATED IN NEUROBLASTOMA
EP1457557A4 (en) NEW CORRESPONDING PROTEINS AND DNA
ATE512977T1 (en) HCV CORE PROTEIN SEQUENCES
ITRM20010670A1 (en) RECOMBINANT PLANTS AND DNA BUILT.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040322

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050503

17Q First examination report despatched

Effective date: 20050620

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20050818